---
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/291085311.md"
description: "The Hang Seng Index rose over 2% during the day, with CSPC PHARMA, INNOVENT BIO, and Baidu leading the constituent stocks. The Hang Seng TECH Index continues to strengthen, currently up 3.5%"
datetime: "2026-06-29T03:10:23.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/291085311.md)
  - [en](https://longbridge.com/en/news/291085311.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/291085311.md)
---

# 

The Hang Seng Index rose over 2% during the day, with CSPC PHARMA (01093.HK), INNOVENT BIO (01801.HK), and Baidu (09888.HK) leading the constituent stocks. The Hang Seng TECH Index continues to strengthen, currently up 3.5%

### Related Stocks

- [00HSI.HK](https://longbridge.com/en/quote/00HSI.HK.md)
- [09888.HK](https://longbridge.com/en/quote/09888.HK.md)
- [BIDU.US](https://longbridge.com/en/quote/BIDU.US.md)
- [01801.HK](https://longbridge.com/en/quote/01801.HK.md)
- [STECH.HK](https://longbridge.com/en/quote/STECH.HK.md)
- [01093.HK](https://longbridge.com/en/quote/01093.HK.md)
- [03115.HK](https://longbridge.com/en/quote/03115.HK.md)
- [02800.HK](https://longbridge.com/en/quote/02800.HK.md)
- [07200.HK](https://longbridge.com/en/quote/07200.HK.md)
- [07300.HK](https://longbridge.com/en/quote/07300.HK.md)
- [07500.HK](https://longbridge.com/en/quote/07500.HK.md)
- [03032.HK](https://longbridge.com/en/quote/03032.HK.md)
- [03033.HK](https://longbridge.com/en/quote/03033.HK.md)
- [03067.HK](https://longbridge.com/en/quote/03067.HK.md)
- [07226.HK](https://longbridge.com/en/quote/07226.HK.md)
- [07552.HK](https://longbridge.com/en/quote/07552.HK.md)
- [07266.HK](https://longbridge.com/en/quote/07266.HK.md)
- [89888.HK](https://longbridge.com/en/quote/89888.HK.md)

## Related News & Research

- [CSPC starts China Phase III trial of SYS6010-enlonstobart combo in driver gene-negative NSCLC](https://longbridge.com/en/news/290946540.md)
- [Innovent Biologics Shareholders Approve All AGM Resolutions, Strengthening Capital Flexibility](https://longbridge.com/en/news/290747206.md)
- [CSPC Pharma trustee buys 2,900,000 shares for HK$19.84 million under 2026 share award scheme](https://longbridge.com/en/news/290552646.md)
- [Baidu's AI chip unit Kunlunxin targets $50 billion Hong Kong IPO, The Information reports](https://longbridge.com/en/news/291063810.md)
- [Innovent Biologics Details Board and Committee Structure to Strengthen Governance](https://longbridge.com/en/news/290749258.md)